Pazufloxacin

DB11774InvestigationalSmall molecule

Pazufloxacin is under investigation in clinical trial NCT02592096 (Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol).

Chemical structure of Pazufloxacin
Mechanism
Curator reviewed
Formula / weight
C16H15FN2O4 · 318.304 g/mol (avg)
Code names
T-3761

Resolves to

Compound
UNII4CZ1R38NDICAS127045-41-4ChEMBLCHEMBL240163ChEBI94700PubChem65957
Clinical / RWD
ATCJ01MA18
Structure
InChIKeyXAGMUUZPGZWTRP-ZETCQYMHSA-NSMILES[H][C@]1(C)COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2C1(N)CC1
Targets
P0AFI2parCP0A0K8gyrBP20831gyrA

What you can answer from here — as of August 30, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
959Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 18 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pazufloxacin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In